Boston Scientific (BSX) stock rose 1.11% but underperformed the market, with upcoming earnings report

From Nasdaq: 2025-04-11 18:15:00

Boston Scientific (BSX) closed at $93.67, up 1.11% from the previous day. The stock underperformed the S&P 500, which gained 1.81%. Shares fell 2.86% last month, outperforming the Medical sector and S&P 500. Earnings report expected on April 23, with an estimated EPS of $0.67 and revenue of $4.56 billion.

Analysts predict BSX earnings of $2.85 per share and revenue of $19.13 billion for the full year, up 13.55% and 14.21% respectively. Zacks Rank #3 (Hold) reflects unchanged EPS estimates. Forward P/E ratio at 32.52 is higher than the industry average of 14.73. Industry Rank at 177 out of 250+.

Zacks names a top semiconductor stock with strong growth potential. Positioned to meet demand for AI, ML, and IoT, the industry is projected to grow from $452 billion in 2021 to $803 billion by 2028. See this stock for free to capitalize on the expanding market.



Read more at Nasdaq: Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note